Resmed (RMD) Income from Continuing Operations (2009 - 2026)
Resmed's (RMD) quarterly Income from Continuing Operations came in at 398732000.0 in Q1 2026, up 9.23% YoY from 365041000.0 in Q1 2025, and up 1.56% on a QoQ basis from 392593000.0 in Q4 2025.
Resmed (RMD) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Resmed (RMD) has 18 years of Income from Continuing Operations data on file, last reported at 398732000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 9.23% year-over-year to 398732000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1519566000.0 (up 15.71% YoY) and the FY2025 annual result came in at 1400723000.0, up 37.2% from the prior year.
- Income from Continuing Operations improved to 398732000.0 in Q1 2026, from 392593000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 398732000.0 in Q1 2026 to a low of 179012000.0 in Q1 2022.
- A 5-year average of 284303705.88 and a median of 292236000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations jumped 328.1% — and 2023, when it slipped 7.16%.
- Tracing RMD's Income from Continuing Operations over 5 years: stood at 224914000.0 in 2022, then dropped by 7.16% to 208800000.0 in 2023, then soared by 65.05% to 344622000.0 in 2024, then increased by 13.92% to 392593000.0 in 2025, then advanced by 1.56% to 398732000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 398732000.0 (Q1 2026), 392593000.0 (Q4 2025), and 348536000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 108.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 383.43 Mn |
| Mar 31, 2026 | 398.73 Mn |
| Dec 31, 2025 | 392.59 Mn |
| Sep 30, 2025 | 348.54 Mn |
| Jun 30, 2025 | 379.71 Mn |
| Mar 31, 2025 | 365.04 Mn |
| Dec 31, 2024 | 344.62 Mn |
| Sep 30, 2024 | 311.36 Mn |
| Jun 30, 2024 | 292.24 Mn |
| Mar 31, 2024 | 300.49 Mn |
| Dec 31, 2023 | 208.80 Mn |
| Sep 30, 2023 | 219.42 Mn |
| Jun 30, 2023 | 229.66 Mn |
| Mar 31, 2023 | 232.50 Mn |
| Dec 31, 2022 | 224.91 Mn |
| Sep 30, 2022 | 210.48 Mn |
| Jun 30, 2022 | 195.06 Mn |
| Mar 31, 2022 | 179.01 Mn |
| Dec 31, 2021 | 201.75 Mn |
| Sep 30, 2021 | 203.61 Mn |